Patient Safety: Safe Practices in Oral Anticancer Medications: Implications for Community Practice
Presentation-Password Protected-PLEASE NOTE ignore the opening comments as these relate to the live webinar, of which this is a recorded version. Allow time for the presentation to buffer and download. Also you will sign in differently with this activity, Password only!
In this knowledge-based continuing pharmacy education activity Dr Lisa Holle, PharmD, BCOP, FHOPA discusses safe practices when working with oral anticancer medications in the community pharmacy.
Community Pharmacists who are interested in or involved in the handling of oral anticancer medications.
This activity is not accredited for technicians.
At the conclusion of the activity, pharmacists will be able to:
- Describe common dispensing and administration challenges with oral anticancer medications
- Identify potentially significant drug-drug interactions with oral anticancer medications
- Describe proper handling and disposal of oral anticancer medications
Lisa M. Holle, Pharm.D., BCOP, FHOPA
Assistant Clinical Professor
Department of Medicine
UConn School of Medicine, Farmington, CT
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Lisa Holle, PharmD, BCOP, FHOPA has no actual or potential conflicts of interest associated with this presentation.
Click on the registration link to register for this activity. The cost is $15.00.
This activity has no funding.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hour (0.1 CEU) will be awarded to pharmacists who submit the assessment successfully with a passing grade of 70% and complete the evaluation. (ACPE #0009-0000-16-074-H05-P). Credits will be electronically transmitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: December 16, 2016
Planned expiration date: December 16, 2019